Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.09 Up 0.14(2.35%) 4:00PM EDT
|After Hours : 6.07 Down 0.02 (0.33%) 6:32PM EDT
Prev Close:5.95
Open:5.93
Bid:6.08 x 3000
Ask:6.10 x 200
1y Target Est:9.44
Beta:1.22
Next Earnings Date: 6-Aug-14ARIA Earnings announcement
Day's Range:5.85 - 6.17
52wk Range:2.15 - 23.00
Volume:5,366,001
Avg Vol (3m):8,330,170
Market Cap:1.14B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 2.35%1.14B
NVSDown 0.32%219.04B
PFEUp 0.23%191.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.04
Quarterly EPS Est (Jun-14) :-0.29
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback